Splenic marginal zone lymphoma (SMZL) is an indolent B cell malignancy usually involving
spleen, bone marrow and blood. The disease presents as an incidental finding or with …

Splenic marginal zone lymphoma (SMZL) is a specific low-grade small B-cell lymphoma that
is incorporated in the World Health Organization classification. Characteristic features are …

Splenic marginal zone lymphoma (SMZL) is an indolent small B-cell lymphoma involving the
spleen and bone marrow characterized by a micronodular tumoral infiltration that replaces …

Splenic marginal zone lymphoma (SMZL) is an indolent lymphoproliferative disease
accounting for approximately 1% of all lymphomas. SMZL presents with marked …

Splenic marginal zone lymphoma (SMZL) is a lymphoma recognized as a distinct entity in
the WHO classification of the lymphoid tumors. SMZL probably results from the expansion of …

Splenic marginal zone lymphoma (SMZL) is a rare B-cell malignancy involving the spleen,
bone marrow, and frequently the blood. SMZL lymphomagenesis involves antigen and/or …

Splenic marginal zone cell lymphoma (SMZCL) is a recently described clinicopathologic
entity, that is reported to overlap with splenic B-cell lymphoma with villous lymphocytes. The …

Splenic marginal zone lymphoma (SMZL) is a recently described and distinctive type of
splenic lymphoma and is characterized by an indolent clinical course. By analyzing a large …

Since the initial description of splenic marginal zone lymphoma (SMZL) in 1992, an
increasing number of publications have dealt with multiple aspects of SMZL diagnosis …

Splenic marginal zone lymphoma (SMZL) is a rare chronic B-cell lymphoproliferative
disorder recognized as a distinct entity in the World Health Organization (WHO) …